Drug Discovery Informatics Market is Expected to Grow more than US$ 6 Billion By 2022

Share this news:

The Global Drug Discovery Informatics Market is expected to exceed more than US$ 6 Billion by 2022.

-- New York, November 19, 2018: The drug discovery is the method in which new applicant medications are discovered. Drug discovery informatics is used in many fields such as in pharmacology, biotechnology and in medicine. Drug discovery involves the medicinal chemistry, screening hits and optimization of those hits to increase oral bioavailability, metabolic stability, efficacy, selectivity and affinity. With the beginning of innovative analytics and cloud based technology, it is feasible to store, process and analyze huge amount of data sets at lower price.

The Global Drug Discovery Informatics Market is expected to exceed more than US$ 6 Billion by 2022.

Browse Full Report: https://www.marketresearchengine.com/reportdetails/drug-discovery-informatics-market

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Infosys, Certara, Charles River Laboratories, Boehringer Ingelheim GmbH, Albany Molecular Research, Selvita, DiscoverX, GVK Biosciences, ChemAxon, Novo Informatics and Jubilant Biosys. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

Market Research Engine has published a new report titled as “Drug Discovery Informatics Market by Workflow Analysis (Development Informatics, Discovery Informatics), By Mode Analysis (In-house Informatics, Outsourced Informatics) and By Service Analysis - Global Industry Analysis and Forecast by 2022”

The scope of the report includes a detailed study of global and regional markets for Global Drug Discovery Informatics Market with the reasons given for variations in the growth of the industry in certain regions.

Reasons to Buy this Report:

1) Obtain the most up to date information available on all Global Drug Discovery Informatics Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast Global Drug Discovery Informatics Market data.
4) Assess your competitor’s refining portfolio and its evolution.

The Global Drug Discovery Informatics Market has been segmented as below:

The Global Drug Discovery Informatics Market this market is segmented on the basis of Workflow Analysis, Mode Analysis, Service Analysis and Regional Analysis.

By Workflow Analysis is segmented on the basis of Development informatics and Discovery informatics. By Mode Analysis this market is segmented on the basis of In-house Informatics and Outsourced Informatics. By Service Analysis is segmented on the basis of Clinical Trial Data Management, Sequence Analysis Platforms, Docking, Molecular Modeling and Others. By Regional Analysis this market is segmented on the basis of Cobalt Alloys, Absorbable Magnesium Alloys, Nickel-Titanium Alloys and Stainless Steel.

Request Sample Report from here: https://www.marketresearchengine.com/reportdetails/drug-discovery-informatics-market

 

Table of Contents

1 INTRODUCTION

2 Research Methodology

3 Executive Summary

4 E-Prescribing Market : Premium Insights

5 Market Overview

6 Industry Insights

8 Global E-Prescribing Market, By Delivery Mode

9 Global E-Prescribing Market, By End User

10 Global E-Prescribing Market, By Region

10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 U.K.
10.3.2 France
10.3.3 Germany
10.3.4 Spain
10.3.5 Sweden
10.3.6 Netherlands
10.3.7 Denmark
10.3.8 Rest of Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 Australia
10.4.3 Rest of Asia-Pacific
10.5 Latin America
10.6 Middle East & Africa

11 Competitive Landscape

12 Company Profiles

Certara

Charles River Laboratories

Boehringer Ingelheim GmbH

Albany Molecular Research

Selvita

DiscoverX

GVK Biosciences

ChemAxon

Novo Informatics

Jubilant Biosys

Other Related Market Research Reports:

Digital Health Monitoring Market is Determined to Cross Billion By 2024

E Health Market is Expected to Grow US$ 136 Billion by 2024

Endoscope Reprocessing Market is Determined to Cross US$ 2.0 Billion By 2022

Contact Info:
Name: John Bay
Email: Send Email
Organization: Market Research Engine
Website: https://www.marketresearchengine.com/

Release ID: 447356

CONTACT ISSUER
Name: John Bay
Email: Send Email
Organization: Market Research Engine
SUBSCRIBE FOR MORE